Sign up to save your podcasts
Or
Share Ep 98: The Future of Alzheimer's Trials: Bringing Cutting-Edge Research to Every Community - John Dwyer, CEO of The Global Alzheimer's Platform
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Ep 98: The Future of Alzheimer's Trials: Bringing Cutting-Edge Research to Every Community - John Dwyer, CEO of The Global Alzheimer's Platform
BrainStorm wants to hear from you! Send us a text.
The quest to speed up clinical trials is personal for John Dwyer, CEO of the Global Alzheimer's Platform (GAP). A long-time UsA2 advocate, he’s been motivated by the generations of family members lost to Alzheimer's and Parkinson's disease. Dwyer shares with BrainStorm host Meryl Comer the critical challenges of NIH funding cuts by the Trump Administration, forcing many trial sites to shut down at a time of new FDA-cleared blood tests for early diagnosis. Dwyer highlights GAP's innovations in improving the participant experience through streamlining visits, personalized feedback, and bringing mobile trials directly to small communities. This must listen episode reinforces clinical trial participation as a valuable care option while advancing research for millions affected by Alzheimer's and related dementias.
This episode of BrainStorm is sponsored by Johnson & Johnson
Support the show
View all episodes
By Meryl Comer, UsAgainstAlzheimer's
4.7
1414 ratings
BrainStorm wants to hear from you! Send us a text.
The quest to speed up clinical trials is personal for John Dwyer, CEO of the Global Alzheimer's Platform (GAP). A long-time UsA2 advocate, he’s been motivated by the generations of family members lost to Alzheimer's and Parkinson's disease. Dwyer shares with BrainStorm host Meryl Comer the critical challenges of NIH funding cuts by the Trump Administration, forcing many trial sites to shut down at a time of new FDA-cleared blood tests for early diagnosis. Dwyer highlights GAP's innovations in improving the participant experience through streamlining visits, personalized feedback, and bringing mobile trials directly to small communities. This must listen episode reinforces clinical trial participation as a valuable care option while advancing research for millions affected by Alzheimer's and related dementias.
This episode of BrainStorm is sponsored by Johnson & Johnson
Support the show
More shows like BrainStorm by UsAgainstAlzheimer's
View all
STEM-Talk
659 Listeners
Nutrition Facts with Dr. Greger
3,458 Listeners
Next Question with Katie Couric
4,869 Listeners
BiggerPockets Money Podcast
3,083 Listeners
Start Here
6,436 Listeners
The Genius Life
4,902 Listeners
The Dr. Hyman Show
9,225 Listeners
Chasing Life
8,191 Listeners
Consider This from NPR
6,401 Listeners
SmartLess
58,080 Listeners
Money For Couples with Ramit Sethi
3,438 Listeners
All There Is with Anderson Cooper
10,532 Listeners
The Mel Robbins Podcast
20,090 Listeners
Fat Science
165 Listeners
The Oprah Podcast
1,698 Listeners